Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function
ERs can act through genomic and non-genomic pathways in PCa. In the genomic pathway, estrogen triggers the dimerization of ERs and their nuclear translocation to regulate the transcriptional activity of genes. ERs can directly control the transcription of genes bearing the estrogen response element (ERE) in their promoter region. In addition, ERs can modulate gene transcription through protein−protein interactions with other transcription factors (TF), which can mediate the recruitment of ERs at promoters without EREs. In the non-genomic pathway, membrane-associated ERs can participate in signal transduction and modulate the activation of key enzymes and molecular pathways, thus resulting in the indirect regulation of transcriptional programs. Known ER-regulated transcriptional programs in PCa: (I) ERα: transactivation of proliferative, apoptotic, survival, differentiation, vasodilation, autophagy, and inflammation targets; transactivation of oncogenes and non-coding RNAs. (II) ERβ1 transactivation of apoptotic, anti-proliferative, anti-invasive, and anti-inflammatory targets; repression of AR, oncogenes, and hypoxic genes. (III) ERβ2 and ERβ5—stabilization of the HIF-1α protein and induction of hypoxic genes. Created with BioRender.com, accessed on 10 July 2023.